This Week in Psychedelics - 1.7.22

Cannabis

  • Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

  • Legal recreational marijuana sales begin in Montana (KPAX)

  • Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

  • New year rings in key changes to state marijuana markets (Marijuana Business Daily)

  • GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

  • Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

  • The top cannabis research studies of 2021 (Leafly)

  • Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

  • Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

  • Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

  • New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

  • South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

  • Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

  • Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

  • The cost of medical marijuana in Louisiana (KSLA)

  • Israeli startup a go-to resource in medical cannabis world (I24News)

  • Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

  • Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

  • Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

  • COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

  • New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

  • Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

  • Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

  • Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

  • Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

  • Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

  • IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

  • Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

  • National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

  • Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

  • MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

  • Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

  • Using cannabinoids to treat obesity (Medical Xpress)

  • More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

  • Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

  • PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

  • The Promises and Perils of Psychedelic Health Care (The New York Times)

  • Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

  • Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

  • Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

  • Psychedelics in 2022: What to Expect (Truffle Report)

  • Fact Check-London Mayor not decriminalising drugs (Reuters)

  • Psychedelics 2021: A Year in Review (Psilocybin Alpha)

  • Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

  • Philippines' Duterte says will never apologise for drug war deaths (Reuters)

  • New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

  • Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

  • How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

  • Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

  • Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

  • Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

  • Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

  • Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

  • Startup To Host Psychedelic Trips In The Metaverse (Forbes)

  • Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.